FindTrial
Sign In

C-Reactive Protein and COVID-19 Patients

C-Reactive Protein and Outcomes of COVID-19 Patients Admitted in a Charitable Hospital - A Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/11/038183
Enrollment
1000
Registered
2021-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A00-B99- Certain infectious and parasitic diseases

Interventions

None listed

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients Diagnosed with COVID-19 Positive COVID-19 Patients Admiteed in Hospital from April 2020 to March 2021 COVID-19 Patients with comorbidities

Exclusion criteria

Exclusion criteria: Patients referred to other hospitals Patients with incomplete medical records Pregnant Patients

Design outcomes

Primary

MeasureTime frame
This study aims to predict survival rate and severity of COVID-19 patients using CRP as a potential biomarkerTimepoint: Date of Admission to date of Discharge—

Secondary

MeasureTime frame
NilTimepoint: Date of Admission to date of Discharge—

Countries

India

Contacts

Public ContactDr Supriya P S

NGSM Institute of Pharmaceutical Sciences

udayvenkatmateti@gmail.com8861796017

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026